Overview

Study to Evaluate the Effects of Colesevelam on Insulin Sensitivity and ß-Cell Function in Subjects With Impaired Fasting Glucose (Prediabetes)

Status:
Completed

Trial end date:
2010-10-01

Target enrollment:

Participant gender:

Summary

The objective of this study is to determine the effect of 8 weeks of treatment with colesevelam HCl 3.75 g once daily with the evening meal on ß-cell function by evaluating the acute insulin response (AIRg) to an intravenous glucose load in subjects with prediabetes (impaired fasting glucose).

Phase:

Phase 3

Details

Lead Sponsor:

Seattle Institute for Biomedical and Clinical Research

Collaborator:

VA Puget Sound Health Care System

Treatments:

Colesevelam Hydrochloride
Insulin